Literature DB >> 18475517

Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria.

C Y Yang1, C L Meng, P Y Wong.   

Abstract

The human parathyroid hormone N-terminal fragment [hPTH-(1-34)] increases the conversion of exogenous unsaturated fatty acids to prostaglandins (PGs) in calvarial homogenates. Enzyme activities were completely blocked by indomethacin (5 x 10(-7) M), a PG synthase inhibitor, and actinomycin D (5 muM), an inhibitor of transcription, by binding to DNA. In addition, a potent inhibitor of protein synthesis, cycloheximide (10 muM), totally inhibited the stimulating effect of hPTH-(1-34) on prostaglandin endoperoxide synthase (PG synthase, EC 1.14.99.1). The stimulatory effect of hPTH-(1-34) on PG synthase was also reduced by the addition of stannous chloride. However, epidermal growth factor (EGF), platelet-derived activating factor (PDGF), and ionophore A23187 did not show the same stimulating effect as hPTH-(1-34) on PG synthase in calvaria. The results further demonstrated that PG synthase is a membrane-bound enzyme in chick calvaria. In this communication, evidence is presented that hPTH-(1-34) stimulates the de novo synthesis of PG synthase as demonstrated by the increased activity in calvarial homogenates and microsomes.

Entities:  

Year:  1993        PMID: 18475517      PMCID: PMC2365390          DOI: 10.1155/S0962935193000213

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  32 in total

1.  Epidermal growth factor: effects of androgens and adrenergic agents.

Authors:  R L Byyny; D N Orth; S Cohen; E S Doyne
Journal:  Endocrinology       Date:  1974-09       Impact factor: 4.736

2.  Activation of skeletal adenyl cyclase by parathyroid hormone in vitro.

Authors:  L R Chase; S A Fedak; G D Aurbach
Journal:  Endocrinology       Date:  1969-04       Impact factor: 4.736

3.  Aspirin inhibition of in vitro osteolysis stimulated by parathyroid hormone and PGE1.

Authors:  T J Powles; D M Easty; G C Easty; P K Bondy; A Munro-Neville
Journal:  Nat New Biol       Date:  1973-09-19

4.  Bovine parathyroid hormone: minimum chain length of synthetic peptide required for biological activity.

Authors:  G W Tregear; J Van Rietschoten; E Greene; H T Keutmann; H D Niall; B Reit; J A Parsons; J T Potts
Journal:  Endocrinology       Date:  1973-12       Impact factor: 4.736

5.  Orientation of the active site and antigenic determinants of prostaglandin endoperoxide synthase in the endoplasmic reticulum.

Authors:  D L DeWitt; T E Rollins; J S Day; J A Gauger; W L Smith
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

6.  The effect of parathyroid hormone upon release of degradative enzymes from rat bone.

Authors:  R L Cruess; K C Hong; F Nakamura
Journal:  Proc Soc Exp Biol Med       Date:  1979-10

7.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

Authors:  M Hamberg; J Svensson; T Wakabayashi; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

8.  Phosphatidylcholine metabolism in neonatal mouse calvaria.

Authors:  P H Stern; D E Vance
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

9.  Synthetic human parathyroid hormone fragment stimulates prostaglandin E2 synthesis by chick calvariae.

Authors:  C Y Yang; W A Gonnerman; L Taylor; R B Nimberg; P R Polgar
Journal:  Endocrinology       Date:  1987-01       Impact factor: 4.736

10.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets.

Authors:  M Hamberg; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.